These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29478340)

  • 1. [Diagnosis and treatment of chronic hepatitis B and D. National consensus guideline in Hungary from 22 September 2017].
    Horváth G; Gerlei Z; Gervain J; Lengyel G; Makara M; Pár A; Rókusz L; Szalay F; Tornai I; Werling K; Hunyady B
    Orv Hetil; 2018 Feb; 159(Suppl 1):24-37. PubMed ID: 29478340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment of chronic hepatitis B and D. National consensus guideline in Hungary from 15 October 2016].
    Horváth G; Gerlei Z; Gervain J; Lengyel G; Makara M; Pár A; Rókusz L; Szalay F; Tornai I; Werling K; Hunyady B
    Orv Hetil; 2017 Feb; 158(Suppl 1):23-35. PubMed ID: 28218868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline].
    Horváth G; Hunyady B; Gervain J; Lengyel G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
    Orv Hetil; 2014 Mar; 155 Suppl():25-36. PubMed ID: 24631887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Not Available].
    Horváth G; Gerlei Z; Gervain J; Lengyel G; Makara M; Pár A; Rókusz L; Szalay F; Tornai I; Werling K; Hunyady B
    Orv Hetil; 2015 Dec; 156 Suppl 2():25-36. PubMed ID: 26667112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Horváth G; Gerlei Z; Gervain J; Lengyel G; Makara M; Pár A; Rókusz L; Szalay F; Telegdy L; Tornai I; Werling K; Hunyady B
    Orv Hetil; 2015 Mar; 156 Suppl 1():25-35. PubMed ID: 26039414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].
    Makara M; Horváth G; Gervain J; Pár A; Szalay F; Telegdy L; Tornai I; Ujhelyi E; Hunyady B
    Orv Hetil; 2012 Mar; 153(10):375-94. PubMed ID: 22370225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline].
    Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
    Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis C: diagnosis, anti-viral therapy, after-care. Hungarian consensus guideline].
    Hunyady B; Gerlei Z; Gervain J; Horváth G; Lengyel G; Pár A; Rókusz L; Szalay F; Telegdy L; Tornai I; Werling K; Makara M
    Orv Hetil; 2015 Mar; 156(9):343-51. PubMed ID: 25702254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 22 September 2017].
    Hunyady B; Gerlei Z; Gervain J; Horváth G; Lengyel G; Pár A; Péter Z; Rókusz L; Schneider F; Szalay F; Tornai I; Werling K; Makara M
    Orv Hetil; 2018 Feb; 159(Suppl 1):3-23. PubMed ID: 29478339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 15 October 2016].
    Hunyady B; Gerlei Z; Gervain J; Horváth G; Lengyel G; Pár A; Péter Z; Rókusz L; Schneider F; Szalay F; Tornai I; Werling K; Makara M
    Orv Hetil; 2017 Feb; 158(Suppl 1):3-22. PubMed ID: 28218867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Not Available].
    Hunyady B; Gerlei Z; Gervain J; Horváth G; Lengyel G; Pár A; Rókusz L; Szalay F; Telegdy L; Tornai I; Werling K; Makara M
    Orv Hetil; 2015 Mar; 156 Suppl 1():3-23. PubMed ID: 26039413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Not Available].
    Hunyady B; Gerlei Z; Gervain J; Horváth G; Lengyel G; Pár A; Péter Z; Rókusz L; Schneider F; Szalay F; Tornai I; Werling K; Makara M
    Orv Hetil; 2015 Dec; 156 Suppl 2():3-24. PubMed ID: 26667111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference.
    Shamliyan TA; MacDonald R; Shaukat A; Taylor BC; Yuan JM; Johnson JR; Tacklind J; Rutks I; Kane RL; Wilt TJ
    Ann Intern Med; 2009 Jan; 150(2):111-24. PubMed ID: 19124812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and therapy of hepatitis B virus infection: Czech national guidelines].
    Husa P; Šperl J; Urbánek P; Fraňková S; Plíšek S; Kümpel P; RoŽnovský L
    Klin Mikrobiol Infekc Lek; 2017 Dec; 23(4):148-164. PubMed ID: 29378384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interdisciplinary aspects of and new drugs for chronic hepatitis B].
    Horváth G
    Orv Hetil; 2013 Jul; 154(29):1142-50. PubMed ID: 23853347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic hepatitis B: Evolution over two decades.
    Yuen MF; Lai CL
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of viral hepatitis B.
    Pramoolsinsup C
    J Gastroenterol Hepatol; 2002 Feb; 17 Suppl():S125-45. PubMed ID: 12000599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil.
    Goyal A; Romero-Severson EO
    PLoS One; 2018; 13(9):e0203831. PubMed ID: 30192887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.